Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Intercept Pharmaceuticals Company Profile (NASDAQ:ICPT)

Consensus Ratings for Intercept Pharmaceuticals (NASDAQ:ICPT) (?)
Ratings Breakdown: 1 Sell Rating(s), 4 Hold Rating(s), 12 Buy Rating(s)
Consensus Rating:Buy (Score: 2.65)
Consensus Price Target: $345.50 (17.55% upside)

Current Analysts' Coverage Summary for Intercept Pharmaceuticals (NASDAQ:ICPT)
Show:
DateFirmActionRatingPrice TargetDetailsShare
3/27/2015MLV & Co.Set Price TargetHold$273.00ViewTweet This Rating  Share This Rating on StockTwits
3/27/2015Deutsche BankBoost Price TargetBuy$300.00 -> $400.00ViewTweet This Rating  Share This Rating on StockTwits
3/24/2015WedbushReiterated RatingBuy$493.00ViewTweet This Rating  Share This Rating on StockTwits
3/23/2015Needham & Company LLCSet Price TargetBuy$500.00ViewTweet This Rating  Share This Rating on StockTwits
3/23/2015Leerink SwannBoost Price TargetMarket Perform$205.00 -> $265.00ViewTweet This Rating  Share This Rating on StockTwits
3/23/2015Janney Montgomery ScottSet Price TargetBuy -> Buy$300.00 -> $350.00ViewTweet This Rating  Share This Rating on StockTwits
3/20/2015NomuraSet Price TargetBuy$440.00ViewTweet This Rating  Share This Rating on StockTwits
3/18/2015Robert W. BairdBoost Price TargetBuy$258.00 -> $344.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2015OppenheimerLower Price TargetOutperform$499.00 -> $375.00ViewTweet This Rating  Share This Rating on StockTwits
1/15/2015Cowen and CompanySet Price TargetBuy$420.00ViewTweet This Rating  Share This Rating on StockTwits
12/18/2014Sterne AgeeInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/15/2014Bank of AmericaReiterated RatingBuy$188.00ViewTweet This Rating  Share This Rating on StockTwits
12/3/2014FBR & Co.Lower Price TargetUnderperform$125.00 -> $99.00ViewTweet This Rating  Share This Rating on StockTwits
11/4/2014Summer StreetReiterated RatingPositiveViewTweet This Rating  Share This Rating on StockTwits
8/14/2014TheStreetUpgradeHoldViewTweet This Rating  Share This Rating on StockTwits
7/2/2014Goldman SachsInitiated CoverageNeutral$265.00ViewTweet This Rating  Share This Rating on StockTwits
6/30/2014RBC CapitalInitiated CoverageOutperform$425.00ViewTweet This Rating  Share This Rating on StockTwits
1/13/2014BMO Capital MarketsReiterated RatingOutperformViewTweet This Rating  Share This Rating on StockTwits
1/10/2014Citigroup Inc.Reiterated RatingBuy$60.00 -> $400.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 3/30/2013 forward)